Co-Authors
This is a "connection" page, showing publications co-authored by Thomas Agoritsas and Bram Rochwerg.
Connection Strength
1.700
-
Clinical trials in COVID-19 management & prevention: A meta-epidemiological study examining methodological quality. J Clin Epidemiol. 2021 11; 139:68-79.
Score: 0.239
-
WHO COVID-19 therapeutic guidelines. Lancet. 2021 07 10; 398(10295):117-118.
Score: 0.239
-
Remdesivir for severe covid-19: a clinical practice guideline. BMJ. 2020 07 30; 370:m2924.
Score: 0.224
-
Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline. BMJ. 2018 Dec 18; 363:k5130.
Score: 0.200
-
Corticosteroids in Sepsis: An Updated Systematic Review and Meta-Analysis. Crit Care Med. 2018 09; 46(9):1411-1420.
Score: 0.196
-
Atraumatic (pencil-point) versus conventional needles for lumbar puncture: a clinical practice guideline. BMJ. 2018 May 22; 361:k1920.
Score: 0.192
-
Corticosteroids in sepsis: an updated systematic review and meta-analysis (protocol). BMJ Open. 2017 06 30; 7(6):e016847.
Score: 0.181
-
Prophylaxis against covid-19: living systematic review and network meta-analysis. BMJ. 2021 04 26; 373:n949.
Score: 0.059
-
A living WHO guideline on drugs to prevent covid-19. BMJ. 2021 03 01; 372:n526.
Score: 0.058
-
A living WHO guideline on drugs for covid-19. BMJ. 2020 09 04; 370:m3379.
Score: 0.056
-
Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ. 2020 07 30; 370:m2980.
Score: 0.056